News

May 14, 2008 - Broadlane clients, consisting of approximately 1,100 hospitals, selected ScImage for a three-year ...

Home May 13, 2008
Home
Technology

Boston Scientific has expanded its portfolio with COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN implantable cardioverter defibrillator (ICD), new platforms to treat heart failure and sudden cardiac death.

Home May 13, 2008
Home
28604_1
Feature | Richard R. Rogoski

Efforts to reduce discovery-to-balloon (d-to-b) and door-to-balloon times is sweeping the country as hospitals put in ...

Home May 13, 2008
Home
News

May 13, 2008 - Boston Scientific reported that the FDA cleared its COGNIS cardiac resynchronization therapy ...

Home May 13, 2008
Home
Case Study

The Vivid 7 Dimension is an extraordinary cardiovascular ultrasound system built on a robust platform that empowers ...

Home May 13, 2008
Home
News

May 14, 2008 - A randomized controlled trial conducted by Brigham and Women's Hospital in affiliation with Harvard ...

Home May 13, 2008
Home
28602_3
Feature | Ellen W. Rothschild, RN, MS

As new drug-eluting stents (DES) receive premarket approval (PMA) from the FDA, despite an abrupt downturn in the market ...

Home May 13, 2008
Home
News

May 14, 2008 - Siemens Healthcare will extend its strategic alliance with Biosense Webster by opening up the ACUSON ...

Home May 13, 2008
Home
Technology

May 14, 2008 - St. Jude Medical received both FDA 510(k) clearance and European CE Mark approvals of the IsoFlex Optim pacing lead, small-diameter lead is built on the IsoFlex pacing lead platform, and features the company’s exclusive Optim insulation material.

Home May 13, 2008
Home
28605_1
Feature | Nick Obradovich

The healthcare industry has increasingly integrated the use of robots into many areas of medicine. In intensive care units (ICUs) and operating rooms (ORs), doctors are working with robots hand-in-hand— literally.

Home May 13, 2008
Home
News

May 14, 2008 - St. Jude Medical received both FDA 510(k) clearance and European CE Mark approvals of the IsoFlex Optim ...

Home May 13, 2008
Home
Feature | Maureen Leahy-Patano

Many formerly invasive diagnostic and interventional cardiology procedures have migrated to less invasive or percutaneous options. The subsequent rise in cath lab procedures has increased the need for alternatives to manual compression that promote hemostasis at the access site, allowing for quicker patient ambulation and throughput.

Home May 13, 2008
Home
News

May 14, 2008 - Siemens today said it would extend its strategic alliance with Biosense Webster Inc. by opening up the ...

Home May 13, 2008
Home
Technology

Boston Scientific's ALTRUA family of pacemakers is the first Boston Scientific-branded pacemaker to treat bradycardia ...

Home May 12, 2008
Home
Technology

Medtronic’s Endeavor Zotarolimus-Eluting Coronary Stent System is engineered for the treatment of coronary artery disease. Endeavor uses the Driver bare metal cobalt alloy stent platform and the drug zotarolimus along with the proprietary, biocompatible drug delivery polymer.

Home May 12, 2008
Home
Subscribe Now